 Bette Demasters
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningeal Neoplasms | 1 | 2023 | 97 | 0.740 |
Why?
| | Pituitary Neoplasms | 1 | 2023 | 195 | 0.690 |
Why?
| | Sarcoidosis | 1 | 2023 | 162 | 0.690 |
Why?
| | Central Nervous System Neoplasms | 2 | 2023 | 172 | 0.620 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2023 | 72 | 0.370 |
Why?
| | Lymphoma, Extranodal NK-T-Cell | 1 | 2021 | 11 | 0.350 |
Why?
| | Lymphoma, Follicular | 1 | 2021 | 54 | 0.340 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2021 | 123 | 0.320 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2023 | 261 | 0.310 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 190 | 0.290 |
Why?
| | Granuloma | 1 | 2023 | 97 | 0.190 |
Why?
| | Central Nervous System Diseases | 1 | 2023 | 73 | 0.190 |
Why?
| | West Nile virus | 2 | 2016 | 42 | 0.180 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2318 | 0.160 |
Why?
| | Glioma | 3 | 1998 | 425 | 0.130 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 1997 | 11 | 0.130 |
Why?
| | Brain Neoplasms | 4 | 2008 | 1300 | 0.130 |
Why?
| | Meningioma | 1 | 1997 | 89 | 0.120 |
Why?
| | Presynaptic Terminals | 1 | 2016 | 94 | 0.110 |
Why?
| | Memory Disorders | 1 | 2016 | 185 | 0.110 |
Why?
| | Telomerase | 1 | 1997 | 249 | 0.110 |
Why?
| | Microglia | 1 | 2016 | 257 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2016 | 305 | 0.100 |
Why?
| | Complement System Proteins | 1 | 2016 | 312 | 0.100 |
Why?
| | West Nile Fever | 2 | 2016 | 57 | 0.090 |
Why?
| | Diplopia | 1 | 2021 | 26 | 0.090 |
Why?
| | Pathologists | 1 | 2021 | 18 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3798 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2023 | 16741 | 0.080 |
Why?
| | Central Nervous System | 1 | 2023 | 269 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2021 | 313 | 0.080 |
Why?
| | Biopsy | 2 | 2021 | 1083 | 0.080 |
Why?
| | Herpesvirus 4, Human | 1 | 2021 | 169 | 0.080 |
Why?
| | Neoplasm Grading | 1 | 2021 | 312 | 0.080 |
Why?
| | Pathology, Surgical | 1 | 2008 | 8 | 0.070 |
Why?
| | Spinal Cord Neoplasms | 1 | 2008 | 41 | 0.070 |
Why?
| | Male | 8 | 2023 | 71500 | 0.070 |
Why?
| | Recurrence | 1 | 2021 | 1114 | 0.070 |
Why?
| | Adult | 5 | 2023 | 40013 | 0.070 |
Why?
| | Female | 7 | 2023 | 77251 | 0.060 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 441 | 0.060 |
Why?
| | Aged | 4 | 2023 | 25322 | 0.050 |
Why?
| | Humans | 11 | 2023 | 143560 | 0.050 |
Why?
| | Nervous System Diseases | 1 | 2006 | 280 | 0.050 |
Why?
| | Middle Aged | 4 | 2023 | 35342 | 0.050 |
Why?
| | Stroke | 1 | 2021 | 1213 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1827 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2023 | 8072 | 0.040 |
Why?
| | DNA Primers | 2 | 1998 | 518 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 1998 | 34 | 0.040 |
Why?
| | Bungarotoxins | 1 | 1997 | 47 | 0.030 |
Why?
| | Neurons | 2 | 2016 | 1636 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 334 | 0.030 |
Why?
| | DNA, Neoplasm | 1 | 1997 | 162 | 0.030 |
Why?
| | CA3 Region, Hippocampal | 1 | 2016 | 7 | 0.030 |
Why?
| | Complement Pathway, Classical | 1 | 2016 | 20 | 0.030 |
Why?
| | Spatial Memory | 1 | 2016 | 27 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2021 | 11365 | 0.030 |
Why?
| | Receptors, Nicotinic | 1 | 1997 | 344 | 0.030 |
Why?
| | Brain | 2 | 1997 | 2892 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1062 | 0.030 |
Why?
| | Complement Activation | 1 | 2016 | 412 | 0.020 |
Why?
| | Zinc | 1 | 1995 | 300 | 0.020 |
Why?
| | Schizophrenia | 1 | 1995 | 442 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1511 | 0.020 |
Why?
| | Hippocampus | 1 | 1995 | 948 | 0.020 |
Why?
| | Brain Stem | 1 | 1990 | 96 | 0.020 |
Why?
| | Specimen Handling | 1 | 2008 | 181 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4522 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1997 | 6366 | 0.010 |
Why?
| | Autopsy | 2 | 1997 | 98 | 0.010 |
Why?
| | Animals | 4 | 2016 | 38010 | 0.010 |
Why?
| | Adolescent | 2 | 1997 | 22481 | 0.010 |
Why?
| | Rats | 2 | 1998 | 5610 | 0.010 |
Why?
| | Mice | 1 | 2016 | 18378 | 0.010 |
Why?
| | Gelatinases | 1 | 1998 | 7 | 0.010 |
Why?
| | Collagenases | 1 | 1998 | 24 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 1998 | 106 | 0.010 |
Why?
| | Metalloendopeptidases | 1 | 1998 | 59 | 0.010 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 1998 | 58 | 0.010 |
Why?
| | Macaca radiata | 1 | 1997 | 16 | 0.010 |
Why?
| | Retroviridae | 1 | 1998 | 104 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 65 | 0.010 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 1998 | 138 | 0.010 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 1997 | 97 | 0.010 |
Why?
| | Iodine Radioisotopes | 1 | 1997 | 140 | 0.010 |
Why?
| | Organ Specificity | 1 | 1997 | 311 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1998 | 342 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 1998 | 518 | 0.010 |
Why?
| | Cell Division | 1 | 1998 | 806 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1995 | 47 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 949 | 0.010 |
Why?
| | Nerve Fibers | 1 | 1995 | 102 | 0.010 |
Why?
| | Reference Values | 1 | 1995 | 811 | 0.010 |
Why?
| | Flow Cytometry | 1 | 1998 | 1192 | 0.010 |
Why?
| | Cell Movement | 1 | 1998 | 973 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2531 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1997 | 2852 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1990 | 2779 | 0.000 |
Why?
|
|
Demasters's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|